After extensive interactions with the Health Professionals Council of South Africa (HPCSA) over more than two years, the HPCSA has agreed to activate the category “Cell Biology”, which is currently dormant, to allow for the registration of medical scientists and technicians with the HPCSA.
It is with regret that I write to inform you that the organising committee and SASCeTS executive have decided to postpone the Biennial SASCeTS Conference that was planned to be held in November in conjunctions with SASMO. Obviously, the impact of the SARS-CoV2 pandemic on the ability of speakers and delegates to travel and congregate has forced us to reschedule. We are currently looking for a suitable venue for the second half of 2021 and will inform you as soon as this is confirmed.
To the medical Advisors of all Managed Care Organizations and Medical Insurance Schemes.
In the context of high dose chemotherapy and stem cell transplantation in the era of the COVID-19 pandemic, practices in South Africa are following international guidelines and recommendations, and this memorandum endorses the following...
Circular 53 of 2019: Benefit definition submissions for adult and paediatric Haemotology Oncology conditions
The CMS will follow the 2016 revision of the World Health Organization classification of lymphoid neoplasms, myeloid neoplasms and acute leukemias in the review. Conditions will also be prioritized based on complaints trends observed by the CMS.
Despite the PMB review process that is currently underway, there is an existing gap in the management of some conditions which warrants the need to continuously develop practice guidelines. These guidelines will be updated and reviewed once the PMB review process is finalized.
National Department of Health database of private professionals to provide oncology services to public health sector
We wish to bring to your attention that the National Department of Health is in the process of compiling a database of private health professionals who are prepared to provide oncology services to the public sector with the aim of enhancing diagnosis and treatment of patients with cancer.